...
首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Double Immunohistochemical Staining Method for HIF-1alpha and its Regulators PHD2 and PHD3 in Formalin-fixed Paraffin-embedded Tissues
【24h】

Double Immunohistochemical Staining Method for HIF-1alpha and its Regulators PHD2 and PHD3 in Formalin-fixed Paraffin-embedded Tissues

机译:福尔马林固定石蜡包埋组织中HIF-1alpha及其调节剂PHD2和PHD3的双重免疫组织化学染色方法

获取原文
获取原文并翻译 | 示例
           

摘要

Hypoxia-inducible factor (HIF-1alpha) is expressed in thenuclei of tumor cells under hypoxic conditions, and is regulated,in part, by cytoplasmic prolyl hydroxylases (PHDs). As HIF-1alphais selectively expressed in tumor cells, inhibitors are being devel-oped for cancer therapy. Although methods for the detection ofHIF-1alpha and PHDs are available, an immunohistochemical doublestaining method for these markers in individual tumor cells isnot available. For method development a human squamous cellcarcinoma (SCC) xenograft, A253, was used as a known positivecontrol tissue for HIF-1alpha in well-differentiated areas withoutmicrovessels. This laboratory showed that tumor cells in theseareas are strongly positive for hypoxia markers. Another human,poorly differentiated SCC xenograft, FaDu, without hypoxicareas, was used as a negative control. PHD2 and 3 immunostainingwas optimized individually using the human kidney. To optimizeHIF-1alpha detection the pressure cooker time for antigen retrieval,concentration of the primary antibody, amplification reagent, andDAB development time were decreased. Casein blocking furtherdecreased the background. Double staining resulted in brownnuclei for HIF-1alpha (DAB), and pink cytoplasmic staining forPHD2, 3 (fast red). The isotype-matched controls were negative.Normal human tissues had no detectable HIF-1alpha, but expressedPHD2, 3. The potential use of this new and improved method wasconfirmed by analyzing 15 surgical biopsies of oropharyngeal SCCof which 6 were positive for HIF-1alpha. This new method defined theoptimal conditions for detection of HIF-1alpha and PHDs in indivi-dual tumor cells and could have a diagnostic and therapeuticpotential.
机译:缺氧诱导因子(HIF-1alpha)在缺氧条件下在肿瘤细胞的核中表达,部分受细胞质脯氨酰羟化酶(PHDs)调节。由于HIF-1alpha在肿瘤细胞中选择性表达,因此开发了用于癌症治疗的抑制剂。尽管有检测HIF-1α和PHD的方法,但尚无针对单个肿瘤细胞中这些标志物的免疫组织化学双重染色方法。为了开发方法,人类鳞状细胞癌(SCC)异种移植物A253被用作在没有微血管的高分化区域中HIF-1alpha的已知阳性对照组织。该实验室表明,这些区域的肿瘤细胞对缺氧标记物呈强阳性。另一种人类低分化的SCC异种移植物FaDu,无低氧血症,用作阴性对照。使用人类肾脏分别对PHD2和3免疫染色进行了优化。为了优化HIF-1alpha检测,减少了用于抗原修复的压力锅时间,一抗浓度,扩增试剂和DAB产生时间。酪蛋白阻滞剂进一步降低了本底。双重染色导致HIF-1alpha(DAB)出现褐色核,PHD2,3呈粉红色细胞质染色(鲜红色)。同种型匹配的对照是阴性的。正常人体组织中未检测到HIF-1α,但表达了PHD2,3。通过分析15例口咽SCC活检组织中的6例HIF-1α阳性,证实了这种新方法和改进方法的潜在用途。该新方法确定了检测单个肿瘤细胞中HIF-1α和PHD的最佳条件,并具有诊断和治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号